Delhi Government Drug Controller
- All
- News
-
"Only Chalk Powder, Health Risk": Telangana's "Stop Use" Warning For 3 Drugs
The Telangana government has warned against the consumption of any and all medicines manufactured by Meg Lifesciences after three- MPOD 200, MEXCLAV 625, and CEFOXIM-CV - were found to have "no active ingredient (medicine)".
-
Delhi Chemists Asked Not To Sell Painkillers Without Prescription
The Delhi government's Department of Drugs Control has asked all chemical associations in the city to not sell drugs like Aspirin and Ibuprofen without a doctor's prescription, amid rising incidence of vector-borne diseases.
-
Gautam Gambhir Foundation Illegally Stocked Covid Medicine Fabiflu, High Court Told: Report
The Gautam Gambhir Foundation has been found guilty of non-authorised stocking, procuring and distributing Fabiflu medicine to COVID-19 patients, the Delhi High Court was informed by the Delhi government's drug controller today.
-
12 Delhi Chemist Shops' Licenses Cancelled For Selling Key Drugs Without Prescription
The licences of 12 chemist shops have been suspended by the Delhi government's drugs control department for selling Covid-management drugs without a doctor's prescription, officials said on Wednesday.
-
Delhi High Court Sets Aside Centre's Decision Banning Sale Of Oxytocin
The Delhi High Court Friday set aside the government decision to ban private firms from producing and selling oxytocin, a drug used for inducing labour contractions and controlling bleeding.
-
In Case Against Online Pharmacies, Centre Asked To Explain Stand
The Delhi High Court today sought response of the Centre on a plea seeking direction to authorities to close down "illegal" online pharmacies, which are offering drugs and prescription medicines on their websites.
-
Court Puts On Hold Regulator's Cap On Price Of Itch Guard Cream
The Delhi High Court has put on hold the government's decision to cap the price of well-known anti-fungal cream Itch Guard, manufactured by drug major Reckitt Benckiser, on the company's plea challenging it.
-
Drug Pricing: Don't Take Coercive Steps Against Cipla, Others, Says Court
The Delhi High Court on Tuesday told the government not to take any coercive action against pharmaceutical companies including Novartis India Limited and Cipla Ltd in connection with the notices issued to them for allegedly not ensuring implementation of the revised drug pricing of 2013.
-
Price Controls: Pharma Industry Favours Dialogue With Government, Says Report
After failing to get a stay order from the Delhi High Court on the latest round of drug price control order, the pharmaceuticals industry has called for a dialogue with the regulators to resolve the row, saying such issues are best ironed out through dialogues than in court rooms.
-
"Only Chalk Powder, Health Risk": Telangana's "Stop Use" Warning For 3 Drugs
The Telangana government has warned against the consumption of any and all medicines manufactured by Meg Lifesciences after three- MPOD 200, MEXCLAV 625, and CEFOXIM-CV - were found to have "no active ingredient (medicine)".
-
Delhi Chemists Asked Not To Sell Painkillers Without Prescription
The Delhi government's Department of Drugs Control has asked all chemical associations in the city to not sell drugs like Aspirin and Ibuprofen without a doctor's prescription, amid rising incidence of vector-borne diseases.
-
Gautam Gambhir Foundation Illegally Stocked Covid Medicine Fabiflu, High Court Told: Report
The Gautam Gambhir Foundation has been found guilty of non-authorised stocking, procuring and distributing Fabiflu medicine to COVID-19 patients, the Delhi High Court was informed by the Delhi government's drug controller today.
-
12 Delhi Chemist Shops' Licenses Cancelled For Selling Key Drugs Without Prescription
The licences of 12 chemist shops have been suspended by the Delhi government's drugs control department for selling Covid-management drugs without a doctor's prescription, officials said on Wednesday.
-
Delhi High Court Sets Aside Centre's Decision Banning Sale Of Oxytocin
The Delhi High Court Friday set aside the government decision to ban private firms from producing and selling oxytocin, a drug used for inducing labour contractions and controlling bleeding.
-
In Case Against Online Pharmacies, Centre Asked To Explain Stand
The Delhi High Court today sought response of the Centre on a plea seeking direction to authorities to close down "illegal" online pharmacies, which are offering drugs and prescription medicines on their websites.
-
Court Puts On Hold Regulator's Cap On Price Of Itch Guard Cream
The Delhi High Court has put on hold the government's decision to cap the price of well-known anti-fungal cream Itch Guard, manufactured by drug major Reckitt Benckiser, on the company's plea challenging it.
-
Drug Pricing: Don't Take Coercive Steps Against Cipla, Others, Says Court
The Delhi High Court on Tuesday told the government not to take any coercive action against pharmaceutical companies including Novartis India Limited and Cipla Ltd in connection with the notices issued to them for allegedly not ensuring implementation of the revised drug pricing of 2013.
-
Price Controls: Pharma Industry Favours Dialogue With Government, Says Report
After failing to get a stay order from the Delhi High Court on the latest round of drug price control order, the pharmaceuticals industry has called for a dialogue with the regulators to resolve the row, saying such issues are best ironed out through dialogues than in court rooms.
